Skip to main content
SpringerLink
Log in

Docetaxel Induced Sclerosing Cholangitis

  • Case Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Abbreviations

CT:

Computer tomography

MRI:

Magnetic resonance imaging

LITs:

Liver injury tests

ADT:

Androgen deprivation therapy

References

  1. Sweeney C, Chen Y-H, Carducci MA, et al. Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): an ecog-led phase III randomized trial. J Clin Oncol. 2014;32:5s

    Article  Google Scholar 

  2. Taylor J, Lindor K. Metastatic prostate cancer simulating sclerosing cholangitis. J Clin Gastroenterol. 1993;16:143–145.

    Article  CAS  PubMed  Google Scholar 

  3. Bruno R, Hille D, Riva A, et al. Population pharmacokinetics/pharmacodynamics of docetaxel in phase ii studies in patients with cancer. J Clin Oncol. 1998;16:187–196.

    CAS  PubMed  Google Scholar 

  4. Hirth J, Watkins PB, Strawderman M, Schott A, Bruno R, Baker LH. The effect of an individual’s cytochrome cyp3a4 activity on docetaxel clearance. Clin Cancer Res. 2000;6:1255–1258.

    CAS  PubMed  Google Scholar 

  5. Wils P, Phung-Ba V, Warnery A, et al. Polarized transport of docetaxel and vinblastine mediated by p-glycoprotein in human intestinal epithelial cell monolayers. Biochem Pharmacol. 1994;48:1528–1530.

    Article  CAS  PubMed  Google Scholar 

  6. Lexicomp. Docetaxel: Drug information. 2015. http://www.uptodate.com/contents/docetaxel-drug-information?source=search_result&search=docetaxel&selectedTitle=1%7E150. Accessed 30 June 2015.

  7. Vodovar D, Mongardon N, Moachon L, et al. Severe docetaxel overdose induced by pharmacokinetic interaction with dronedarone. J Clin Oncol. 2011;29:e694–e695.

    Article  PubMed  Google Scholar 

  8. Ho RH, Kim RB. Transporters and drug therapy: implications for drug disposition and disease. Clin Pharmacol Ther. 2005;78:260–277.

    Article  CAS  PubMed  Google Scholar 

  9. Bjornsson TD, Callaghan JT, Einolf HJ, et al. The conduct of in vitro and in vivo drug–drug interaction studies: a phrma perspective. J Clin Pharmacol. 2003;43:443–469.

    Article  CAS  PubMed  Google Scholar 

  10. Imam MH, Talwalkar JA, Lindor KD. Secondary sclerosing cholangitis: pathogenesis, diagnosis, and management. Clin Liver Dis. 2013;17:269–277.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Department of Transplant Hepatology, Mayo Clinic, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, USA

    Jennifer L. Horsley-Silva, Keith D. Lindor & Hugo E. Vargas

  2. Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USA

    Elizabeth N. Dow & Estrella M. Carballido

  3. Division of Radiology, Mayo Clinic, Phoenix, AZ, USA

    Christine O. Menias

  4. Division of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ, USA

    Maxwell L. Smith

Authors
  1. Jennifer L. Horsley-Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth N. Dow
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christine O. Menias
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maxwell L. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Estrella M. Carballido
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Keith D. Lindor
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hugo E. Vargas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hugo E. Vargas.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Horsley-Silva, J.L., Dow, E.N., Menias, C.O. et al. Docetaxel Induced Sclerosing Cholangitis. Dig Dis Sci 60, 3814–3816 (2015). https://doi.org/10.1007/s10620-015-3914-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-015-3914-3

Keywords

Search

Navigation